Showing 2,671 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Daclatasvir for hepatitis C: added benefit not proven

Editor's pick
German Institute for Quality and Efficiency in Health Care (IQWiG)
11 December 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir cures most previously treated hepatitis C patients with cirrhosis

News
10 December 2014
Hepatitis C treatment

Will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?

Editor's pick
Hepatitis C New Drugs
10 December 2014
Exposure to HIV through medical procedures

Pakistani Blood Transfusions Spreading Hepatitis, HIV: Official

Editor's pick
HepatitisCNewDrugs
9 December 2014
Government, leadership & policy

European HIV response "falling behind" as Eastern European epidemic grows

News
5 December 2014
Harm reduction

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

News
3 December 2014
Hepatitis C treatment

Sofosbuvir/ledipasvir with ribavirin cures most people with hepatitis C recurrence after liver transplantation

News
2 December 2014
Hepatitis C treatment

Sofosbuvir + simeprevir shows good results for hepatitis C in real-world use

News
2 December 2014
Hepatitis C treatment

DAAs show good cure rates and liver function improvement for transplant recipients with recurrent HCV

News
27 November 2014
New & experimental hepatitis C treatment

FDA declines to approve Bristol-Myers hepatitis drug

Editor's pick
Reuters
27 November 2014
Hepatitis C treatment

AbbVie 3D regimen cures recurrent HCV in most liver transplant recipients without cirrhosis

News
27 November 2014
Hepatitis C transmission & prevention

"Promising" results in Oxford trials of Hepatitis C vaccine

Editor's pick
Cherwell
26 November 2014
Hepatitis B

Tenofovir continues to suppress hepatitis B virus for eight years

News
25 November 2014
Hepatitis C treatment

Daclatasvir + sofosbuvir demonstrates good cure rate for genotype 3 hepatitis C

News
25 November 2014
Hepatitis C treatment

Deaths of Japanese patients prompt label change for simeprevir

Editor's pick
HCP Live
24 November 2014
New & experimental hepatitis C treatment

CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe

Editor's pick
AbbVie press release
21 November 2014
Hepatitis C treatment

Ooh La La: France Negotiates a Steep Discount for Sovaldi From Gilead

Editor's pick
Wall Street Journal
21 November 2014
Hepatitis C treatment

AbbVie 3D regimen and sofosbuvir/ribavirin show high cure rates for HCV in people with HIV co-infection

News
21 November 2014
New & experimental hepatitis C treatment

Sofosbuvir + GS-5816 for 12 weeks shows high HCV cure rates, but 8 weeks is less effective for some patients

News
19 November 2014
Hepatitis C treatment

NHS asks Nice to delay ground-breaking hepatitis C drug

Editor's pick
Channel 4 News (blog)
19 November 2014
New & experimental hepatitis C treatment

European Commission Grants Marketing Authorization for Gilead’s Harvoni® (Ledipasvir/Sofosbuvir)

Editor's pick
Gilead press release
19 November 2014
Hepatitis C treatment

Practical steps to eliminating hepatitis C: a consensus for London

Editor's pick
London Joint Working Group on Substance Use and Hepatitis C
17 November 2014
Hepatitis C treatment

Interim Revision of Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Editor's pick
AidsInfo
17 November 2014
Hepatitis B

Adding pegylated interferon to tenofovir improves odds of HBsAg loss in hepatitis B patients

News
17 November 2014